课题基金 / 基金详情

Genetically engineered mouse models

Genetically engineered mouse models
基因工程小鼠模型
批准号:
8237579
负责人:
Alain Charest
金额:
$25.86万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Alain Charest的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结(见说明): 基因工程小鼠(GEIVI)品系的利用是GTBT P01计划项目的一个组成部分。小鼠模型核心将提供所有必要的专业知识,试剂和服务,用于分析外泌体生物学在GBM的GEM模型中的治疗应用。该核心提供的服务和试剂将与单个项目协同作用,验证和评估外泌体相关的分子生物标志物,并应用尖端监测技术监测肿瘤对治疗药物的反应。此外,核心将在资助期间生产和表征三种新的GBM GEM菌株。因此,核心将支持这些新的转基因小鼠模型构建的各个方面,包括建议,服务,技术和试剂,以优化每个特定品系的设计和构建。使用这些新菌株,核心还将评估和实施与各个项目密切相关的各种外泌体指标的检测和监测新技术。
英文摘要
PROJECT SUMMARY (See instructions): The utilization of genetically engineered mouse (GEIVI) strains is an integral component of this GTBT P01 program project. The mouse model Core will provide all the necessary expertise, reagents and services for the analysis of exosomal biology with regards to therapeutic applications in GEM models of GBM. The services and reagents provided by this Core will synergize with the individual Projects on the validation and assessment of exosomal-associated molecular biomarkers and the application of cutting edge monitoring technologies for tumor response to therapeutic agents. In addition, the Core will produce and characterize three new GBM GEM strains over the funding period. As such, the Core will support all aspects of the construction of these new transgenic mouse models, including advice, service, technologies and reagents for the optimal design and construction of each specific strain. Using these new strains, the Core will also evaluate and implement new technologies for the detection and monitoring of various exosomal metrics in close relationship with the individual Projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineering T Cell Adoptive Therapy for Glioblastoma
  • 批准号:
    10752995
  • 项目类别:
  • 资助金额:
    $65.84万
  • 财政年份:
    2023
  • 负责人:
    Alain Charest
  • 依托单位:
Therapeutic vulnerabilities associated with PTEN missense mutations
Uncovering exRNA and protein determinants of secreted vesicle heterogeneity by flow cytometric purification of vesicle subsets from cells and plasma
Uncovering exRNA and protein determinants of secreted vesicle heterogeneity by flow cytometric purification of vesicle subsets from cells and plasma
海外基金